Metraipolis › archive › dc_b4dca3893f08

Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A… — Europe PMC PMID:42792865

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42792865
DOI
10.3390/biomedicines14092125
License (as archived)
solo-consultazione
Archived
2026-10-08T02:28:53.627Z
SHA-256 of the archived text
db51ae2a4764de4d03aa1bf5328c1819fdc0017dd00c75295eb94b4f1b78ab3c
Stable URL of this page
https://metraipolis.com/documento/dc_b4dca3893f08

How to cite

Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A… — Europe PMC PMID:42792865 — Europe PMC (en), https://europepmc.org/article/MED/42792865 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4dca3893f08 (Metraipolis archive dc_b4dca3893f08, sha256 db51ae2a4764de4d03aa1bf5328c1819fdc0017dd00c75295eb94b4f1b78ab3c)
BibTeX
@misc{dcb4dca3893f08,
  title = {Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A… — Europe PMC PMID:42792865},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42792865},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4dca3893f08; sha256 db51ae2a4764de4d03aa1bf5328c1819fdc0017dd00c75295eb94b4f1b78ab3c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42792865. Agents can read the archived copy with the MCP tool read_document.